- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 513/06 - Peri-condensed systems
Patent holdings for IPC class C07D 513/06
Total number of patents in this class: 89
10-year publication summary
|
13
|
9
|
5
|
5
|
5
|
0
|
8
|
16
|
2
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Erasca, Inc. | 86 |
8 |
| Merck Patent GmbH | 5812 |
7 |
| LG Chem, Ltd. | 17641 |
5 |
| Onkure, Inc. | 26 |
4 |
| Samsung Display Co., Ltd. | 34984 |
3 |
| FUJIFILM Corporation | 29458 |
3 |
| Piramal Enterprises Limited | 156 |
3 |
| Promega Corporation | 574 |
3 |
| Shionogi & Co., Ltd. | 852 |
3 |
| Bayer Pharma AG | 1052 |
2 |
| Amgen Inc. | 4081 |
2 |
| Abbvie Inc. | 1799 |
2 |
| Purdue Research Foundation | 3638 |
2 |
| Bioimics AB | 3 |
2 |
| Council of Scientific and Industrial Research | 601 |
2 |
| Gilead Sciences, Inc. | 2035 |
2 |
| Sagami Chemical Research Institute | 91 |
2 |
| Tosoh Corporation | 1298 |
2 |
| Prelude Therapeutics, Incorporated | 130 |
2 |
| Samsung Electronics Co., Ltd. | 147003 |
1 |
| Other owners | 29 |